Abbott Laboratories
ABT
$135.08
-$2.63-1.91%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.19% | 2.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.19% | 2.49% | |||
| Cost of Revenue | 5.79% | 3.85% | |||
| Gross Profit | 1.13% | 1.44% | |||
| SG&A Expenses | -0.58% | -0.83% | |||
| Depreciation & Amortization | -1.06% | -0.21% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.39% | 2.26% | |||
| Operating Income | 2.31% | 3.48% | |||
| Income Before Tax | 4.64% | 20.72% | |||
| Income Tax Expenses | -2,548.64% | -3.61% | |||
| Earnings from Continuing Operations | 460.69% | 26.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 460.69% | 26.42% | |||
| EBIT | 2.31% | 3.48% | |||
| EBITDA | 1.86% | 2.31% | |||
| EPS Basic | 458.58% | 27.87% | |||
| Normalized Basic EPS | -2.80% | 6.66% | |||
| EPS Diluted | 460.01% | 27.49% | |||
| Normalized Diluted EPS | -2.33% | 6.15% | |||
| Average Basic Shares Outstanding | 0.38% | -0.66% | |||
| Average Diluted Shares Outstanding | -0.09% | -0.19% | |||
| Dividend Per Share | 7.27% | 0.00% | |||
| Payout Ratio | -0.82% | -0.21% | |||
